Regulation & law · 15/09/2021

Wyeth Pharmaceuticals, LLC Receives Authorization for mRNA Bulk Drug Substance Production in Foreign-Trade Zone 27-Boston, Massachusetts

Wyeth Pharmaceuticals, LLC has been authorized to produce mRNA bulk drug substance in Foreign-Trade Zone 27-Boston, Massachusetts, as part of a proposed production activity.